Skip to main content
. Author manuscript; available in PMC: 2014 Feb 6.
Published in final edited form as: Curr Drug Targets. 2010 Jun;11(6):682–698. doi: 10.2174/138945010791170851

Table 1.

Evaluation of Phytochemicals Targeting GI Cancers in Clinical Trials

Phytochemical GI Cancer Target Phase Result * Reference
Carotenoids Colon - In progress NCT00475722
Epigallocatechin gallate (EGCG) or green tea extracts Esophageal I In progress NCT00233935
Colon II In progress NCT00718094
Resveratrol Colon I In progress NCT00433576
Colon I In progress NCT00578396
Colon I and II In progress NCT00256334
Curcumin Colon I In progress NCT00973869
Colon I Completed NCT00027495
Colon II In progress NCT00118989
Colon - In progress NCT00927485
Colon - Completed NCT00176618
Colon II In progress NCT00745134
Colon III In progress NCT00706121
Colon II In progress NCT00365209
Pancreatic II Completed NCT00094445
*

Indicates reference found at www.clinicaltrials.gov with corresponding identifier code (NCT).